GGrantIndex
← Leaderboards

Ashani T Weeraratna

Wistar Institute

Google Scholar ↗PubMed ↗ORCID ↗
$9,422,460
Attributed
$15,669,514
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.3M · FY2014–25
$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,121,201 · 9

By mechanism

P01$13,541,820 · 3
R01$7,703,921 · 4
T32$3,532,507 · 1
U01$3,342,953 · 1

Top collaborators

Most similar at Wistar Institute

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsMelanomaTumorPlayMelanoma CellSignal TransductionAgingSamplingSkinAgedAffectPathway InteractionsResistanceIn VivoNeoplastic CellFibroblastsGeneticTargeted TreatmentTumor MicroenvironmentMouse ModelProgramsCell LineNeoplasm MetastasisAge Related

Grant awards (44)

Training in Areas Fundamental to Cancer Research$602,528
T32 · FY2025 · CA · contact PI
Recurrence and Resistance in the Aging Melanoma Microenvironment$510,431
R01 · FY2025 · CA · contact PI
Training in Areas Fundamental to Cancer Research$611,949
T32 · FY2024 · CA · contact PI
Targeted Therapies in Melanoma$2,478,587
P01 · FY2023 · CA
Training in Areas Fundamental to Cancer Research$614,536
T32 · FY2023 · CA · contact PI
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$510,277
R01 · FY2023 · CA · contact PI
Targeting Lipid Metabolism in the Tumor Microenvironment$167,328
P01 · FY2023 · CA · contact PI
Targeted Therapies in Melanoma$2,448,186
P01 · FY2022 · CA
Training in Areas Fundamental to Cancer Research$600,700
T32 · FY2022 · CA · contact PI
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$555,518
U01 · FY2022 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$521,990
R01 · FY2022 · CA · contact PI
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$168,700
R01 · FY2022 · CA · contact PI
Targeting Lipid Metabolism in the Tumor Microenvironment$161,373
P01 · FY2022 · CA · contact PI
Targeted Therapies in Melanoma$2,487,446
P01 · FY2021 · CA
Training in Areas Fundamental to Cancer Research$560,236
T32 · FY2021 · CA · contact PI
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$556,945
U01 · FY2021 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$546,285
R01 · FY2021 · CA · contact PI
Effect of the aged microenvironment on tumor dormancy$374,578
R01 · FY2021 · CA · contact PI
Targeting Lipid Metabolism in the Tumor Microenvironment$156,850
P01 · FY2021 · CA · contact PI
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$105,092
R01 · FY2021 · CA · contact PI
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$39,983
U01 · FY2021 · CA
Targeted Therapies in Melanoma$2,498,687
P01 · FY2020 · CA
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$809,629
U01 · FY2020 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$587,690
R01 · FY2020 · CA · contact PI
Training in Areas Fundamental to Cancer Research$542,558
T32 · FY2020 · CA · contact PI
Targeting Lipid Metabolism in the Tumor Microenvironment$446,352
P01 · FY2020 · CA · contact PI
Effect of the aged microenvironment on tumor dormancy$374,578
R01 · FY2020 · CA · contact PI
Targeted Therapies in Melanoma$2,538,781
P01 · FY2019 · CA
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$642,885
U01 · FY2019 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin$597,883
R01 · FY2019 · CA · contact PI
Effect of the aged microenvironment on tumor dormancy$421,585
R01 · FY2019 · CA · contact PI
Targeting Lipid Metabolism in the Tumor Microenvironment$158,230
P01 · FY2019 · CA · contact PI
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$139,492
U01 · FY2019 · CA
A plasticity and reprogramming paradigm for therapy resistance at the single cell level$598,501
U01 · FY2018 · CA
Effect of the aged microenvironment on tumor dormancy$434,625
R01 · FY2018 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$394,250
R01 · FY2018 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$59,339
R01 · FY2018 · CA · contact PI
Effect of the aged microenvironment on tumor dormancy$434,625
R01 · FY2017 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$394,250
R01 · FY2017 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$59,339
R01 · FY2017 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$394,250
R01 · FY2016 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$46,404
R01 · FY2016 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$383,875
R01 · FY2015 · CA · contact PI
Promotion of tumor invasion and pseudosenescence by the aging microenvironment$383,875
R01 · FY2014 · CA · contact PI